|Value based pricing for NHS drugs: an opportunity not to be missed?|
K Claxton, A Briggs, MJ Buxton, AJ Culyer, C McCabe, S Walker, ...
Bmj 336 (7638), 251-254, 2008
|Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion scintigraphy, or NICE guidelines on subsequent unnecessary angiography rates: the CE-MARC 2 …|
JP Greenwood, DP Ripley, C Berry, GP McCann, S Plein, ...
Jama 316 (10), 1051-1060, 2016
|Appropriate perspectives for health care decisions.|
K Claxton, S Palmer, M Sculpher, S Walker
Centre for Health Economics, University of York, 2010
|Sustainable HIV treatment in Africa through viral-load-informed differentiated care|
A Phillips, A Shroufi, L Vojnov, J Cohn, T Roberts, T Ellman, K Bonner, ...
Nature 528 (7580), S68-S76, 2015
|Coverage with evidence development, only in research, risk sharing, or patient access scheme? A framework for coverage decisions|
S Walker, M Sculpher, K Claxton, S Palmer
Value in Health 15 (3), 570-579, 2012
|Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa|
J Hakim, V Musiime, AJ Szubert, J Mallewa, A Siika, C Agutu, S Walker, ...
New England Journal of Medicine 377 (3), 233-245, 2017
|Value for money and the Quality and Outcomes Framework in primary care in the UK NHS|
S Walker, AR Mason, K Claxton, R Cookson, E Fenwick, R Fleetcroft, ...
British Journal of General Practice 60 (574), e213-e220, 2010
|Multicentre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women with primary breast cancer …|
LW Turnbull, SR Brown, C Olivier, I Harvey, J Brown, P Drew, A Hanby, ...
Health technology assessment (Winchester, England) 14 (1), 1-182, 2010
|Endovascular stents for abdominal aortic aneurysms: a systematic review and economic model|
D Chambers, D Epstein, S Walker, D Fayter, F Paton, K Wright, J Michaels, ...
NIHR Health Technology Assessment programme: Executive Summaries, 2009
|Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study|
S Walker, F Girardin, C McKenna, SG Ball, J Nixon, S Plein, ...
Heart 99 (12), 873-881, 2013
|The clinical effectiveness and cost-effectiveness of low-intensity psychological interventions for the secondary prevention of relapse after depression: a systematic review.|
M Rodgers, M Asaria, S Walker, D McMillan, M Lucock, M Harden, ...
Health Technology Assessment (Winchester, England) 16 (28), 1, 2012
|Effectiveness of a national quality improvement programme to improve survival after emergency abdominal surgery (EPOCH): a stepped-wedge cluster-randomised trial|
CJ Peden, T Stephens, G Martin, BC Kahan, A Thomson, K Rivett, D Wells, ...
The Lancet 393 (10187), 2213-2221, 2019
|Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models|
D Keebler, P Revill, S Braithwaite, A Phillips, N Blaser, A Borquez, ...
The Lancet Global Health 2 (1), e35-e43, 2014
|The role of NICE technology appraisal in NHS rationing|
S Walker, S Palmer, M Sculpher
British medical bulletin 81 (1), 51-64, 2007
|A randomised controlled trial of computerised cognitive behaviour therapy for the treatment of depression in primary care: the Randomised Evaluation of the Effectiveness and …|
E Littlewood, A Duarte, C Hewitt, S Knowles, S Palmer, S Walker, ...
Health Technology Assessment (Winchester, England) 19 (101), 1, 2015
|Early infant diagnosis of HIV infection in low-income and middle-income countries: does one size fit all?|
M Penazzato, P Revill, AJ Prendergast, IJ Collins, S Walker, PJ Elyanu, ...
The Lancet Infectious Diseases 14 (7), 650-655, 2014
|Using cost-effectiveness thresholds to determine value for money in low-and middle-income country healthcare systems: are current international norms fit for purpose?|
P Revill, SM Walker, J Madan, A Ciaranello, T Mwase, DM Gibb, ...
Centre for Health Economics, University of York, 2014
|Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal.|
J Burch, S Griffin, C McKenna, S Walker, J Paton, K Wright, N Woolacott
Pharmacoeconomics 30 (11), 991-1004, 2012
|Randomized controlled trial to assess the impact of continuous glucose monitoring on HbA1c in insulin‐treated diabetes (MITRE Study)|
D Cooke, SJ Hurel, A Casbard, L Steed, S Walker, S Meredith, AJ Nunn, ...
Diabetic medicine 26 (5), 540-547, 2009
|Long-term healthcare use and costs in patients with stable coronary artery disease: a population-based cohort using linked health records (CALIBER)|
S Walker, M Asaria, A Manca, S Palmer, CP Gale, AD Shah, KR Abrams, ...
European Heart Journal-Quality of Care and Clinical Outcomes 2 (2), 125-140, 2016